FDA 'Intercenter Institutes' Legislation Headed For Senate Mark-Up

FDA would be directed to test the concept of joint drug/device/diagnostic reviews in at least one therapeutic area; idea of further integrating medical product reviews is also part of Vice President’s cancer 'moonshot.'